Cumulative Irritation Test

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.

Clinical Trial Description

Healthy, adult volunteers of either sex will be patched daily on his/her back with multiple strengths of AN2718 in 2 different topical dosage forms and an active comparator over the course of 21 consecutive days. Twenty-four hours after each application, the patches will be removed and the site evaluated using a five-point scale for irritation. ;

Study Design

Related Conditions & MeSH terms

Tinea Pedis

Clinical Trial Details

NCT number	NCT00781664
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 1
Start date	October 2008
Completion date	November 2008

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05493488` - A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis	Phase 2
Completed	`NCT04883593` - A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.	Early Phase 1
Terminated	`NCT02842021` - Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis	Phase 2
Completed	`NCT01712360` - Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis	Phase 4
Completed	`NCT03676686` - Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis	N/A
Completed	`NCT01519752` - A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis	Phase 1
Completed	`NCT03320486` - Non-inferiority Trial of Dapaconazole Versus Ketoconazole	Phase 3
Completed	`NCT01580891` - Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis	Phase 1
Completed	`NCT01349998` - Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis	Phase 3
Completed	`NCT01353976` - Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis	Phase 3
Completed	`NCT04265521` - Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet	N/A
Completed	`NCT02633813` - BE Study of Naftifine HCL	Phase 3
Recruiting	`NCT00856596` - Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females	Phase 3
Completed	`NCT00869336` - Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)	Phase 2
Completed	`NCT00768599` - A Study of Econazole Foam 1% in Athlete's Foot	Phase 2
Recruiting	`NCT00233493` - Spread of Dermatophytes Among Families	N/A
Completed	`NCT03897257` - A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis	Phase 2
Completed	`NCT03129321` - Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis	Phase 3
Completed	`NCT02335255` - Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis	Phase 1
Withdrawn	`NCT02606383` - Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis	Phase 3